// App-Quantinova.ai

2101239 : DO SECONDGENERATION DRUGELUTING STENTS OUTPERFORM FIRSTGENERATION DRUGELUTING STENTS IN A COMPLEX PATIENT POPULATION: A PROPENSITY SCORE MATCHED ANALYSIS

Researchers

Presenter

  • Joshua Loh

Principal Investigators

  • Hironori Kitabata

  • lakshmana Pendyala

  • Augusto Pichard

  • Ron Waksman

  • Sa'ar Minha

  • Israel Barbash

  • Danny Dvir

  • Salem Badr

  • Rebecca Torguson

  • Kenneth Kent

  • Lowell Satler

  • William Suddath

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved